Thursday, October 10, 2019 3:46:31 PM
Harmel S. Rayat is a prolific investor, entrepreneur and business owner based in Vancouver, Canada.
He is the author of the new book, “Winning with Commercial Real Estate”, and President of Talia Jevan Properties, Inc., a privately held commercial real estate firm specializing in the acquisition and long-term ownership of Class-A commercial real estate assets throughout North America.
When Mr. Rayat isn’t providing investment capital and strategic advice to incumbent management teams of established and start-up companies, he’s spending time with his family and helping people live better lives through his love of science, technology, real estate and investing.
Mr. Rayat brings a unique world view to his work having been born in Uganda and relocating to India before moving with his family to the United Kingdom and then to Vancouver, British Columbia, where he worked as a broker in his early twenties and became interested in early stage companies.
Since 2006, Mr. Rayat has grown his real estate portfolio to nearly $150 million, generating a 33% annual return on equity.
https://www.huffpost.com/author/contact-178
This is one of Mr. Rayat's commercial buildings. Solar Windows has their offices here at 9375 E. Shea Blvd. in Scottsdale, AZ.
This shows his entire complex of commercial buildings.
Recent WNDW News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 08:09:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 08:48:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/21/2023 10:23:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:25:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:23:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/10/2023 08:21:19 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/30/2023 08:27:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM